We are a life science tools company developing a state-of-the-art platform technology uniquely capable of mining a rich seam of new insights from the “dynamic genome”, with significant commercial potential in clinical diagnostics and translational research.
Backed by world-class investors & advisors
Over €30M equity & grant money raised to date
Spin-out from one of France’s top universities
Offices & labs in both Paris and Cambridge, UK
A collaborative & dynamic environment at the cutting edge of science
We have assembled a talented multidisciplinary team from around the world to bring MAGNATM to market
From academic innovation to commercial reality
Depixus® is built on the foundations of the pioneering biophysics research of David Bensimon, Vincent Croquette, & Jean-François Allemand.